Table 2

 Analysis of patients with rheumatoid arthritis (RA) of less than 3 years’ duration who met criteria for inclusion in the early RA (ERA) clinical trial according to therapies taken

Prior methotrexate statusNo. of patientsNo. (%) who met inclusion criteria for ERA clinical trial*
* Inclusion criteria: 12 or more tender joints and 10 or more swollen joints; positive rheumatoid factor or radiographic erosions; morning stiffness of 45 minutes or more or ESR of 28 mm/hr or more.
Source: Sokka et al. Arthritis Rheum 2003;48:313–18.31
No prior methotrexate: first visit198 (42%)
No prior methotrexate: not first visit173 (18%)
All no prior methotrexate3611 (31%)
Prior methotrexate, leflunomide, etanercept or infliximab19626 (13%)
Total—all patients23237 (16%)